Dinali Wijewarnasuriya
About Dinali Wijewarnasuriya
Dinali Wijewarnasuriya is a Senior Scientist currently working at Serotiny in the San Francisco Bay Area. With a PhD in Oncology and Cancer Biology from Weill Cornell Graduate School of Medical Sciences, she has held various research positions, including roles at Memorial Sloan Kettering Cancer Center and Allogene Therapeutics.
Work at Serotiny
Dinali Wijewarnasuriya has been employed as a Senior Scientist at Serotiny since 2022. Located in the San Francisco Bay Area, Serotiny focuses on developing innovative cell therapies. In this role, Wijewarnasuriya contributes to research and development efforts aimed at advancing therapeutic solutions.
Previous Experience at Allogene Therapeutics
Prior to joining Serotiny, Dinali Wijewarnasuriya worked at Allogene Therapeutics as a Senior Scientist from 2021 to 2022. During this year-long tenure, she was involved in the development of allogeneic cell therapies, contributing to the company's mission of improving patient outcomes through innovative treatments.
Postdoctoral Fellowship at Boehringer Ingelheim
Dinali Wijewarnasuriya served as a Postdoctoral Fellow at Boehringer Ingelheim from 2020 to 2021. In this role, she engaged in research projects that focused on drug development and therapeutic strategies, enhancing her expertise in the pharmaceutical industry.
Education and Expertise
Dinali Wijewarnasuriya earned her Doctor of Philosophy (PhD) in Oncology and Cancer Biology from Weill Cornell Graduate School of Medical Sciences, completing her studies from 2013 to 2019. She also holds a Bachelor's degree in Molecular Cell and Developmental Biology from the University of California, Los Angeles. This educational background provides her with a strong foundation in cancer research and cellular biology.
Research Experience at Memorial Sloan Kettering Cancer Center
From 2013 to 2019, Dinali Wijewarnasuriya was a PhD Candidate at Memorial Sloan Kettering Cancer Center. During her six years there, she conducted significant research in cancer biology, contributing to the understanding of cancer mechanisms and potential therapeutic targets.